Abstract
Two 8-year-old small-breed neutered dogs were referred due to respiratory distress caused by a new onset of congestive heart failure secondary to degenerative mitral valve disease. Medical treatment, including a diuretic and a vasodilator, was initiated, and blood samples for evaluating the levels of blood urea nitrogen, creatinine, and N-terminal pro-brain natriuretic peptide (NT-proBNP) were collected at every visit. The two dogs had entirely different outcomes: one is still alive with its symptoms well controlled by the medications, whereas the other one was unstable during the therapeutic period and only survived for 89 days after the diagnosis was made. Serial measurements of NT-proBNP concentration revealed that its gradual decline corresponded to better outcome, whereas fluctuant and ascending concentrations reflected a poor prognosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
